ClinicalTrials.gg
Sign In

Avidity Biosciences, Inc. clinical trials

Acquired by Novartis, Feb 27, 2026 · source ↗

The registry lists 11 studies whose lead sponsor is Avidity Biosciences, Inc.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

Before and after it joined Novartis

First submitted before Avidity Biosciences, Inc. became part of Novartis
10
First submitted after Avidity Biosciences, Inc. became part of Novartis
1
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Avidity Biosciences, Inc.’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Avidity Biosciences, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

The study

Add it to your calendar (.ics) → With an account.

All 11 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now327%Recruiting 2 · Enrolling by invitation 1
  • Under way, not recruiting218%
  • Completed545%
  • Status unknown or other19%

Phase

  • Phase 26
  • Phase 34
  • Phase 13

Where

  • United States10
  • Canada6
  • United Kingdom6
  • Netherlands4
  • Spain4
  • Germany4

Over the years

  1. 21
  2. 22
  3. 23
  4. 324
  5. 25
  6. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Avidity Biosciences, Inc.11 studies

Something wrong with this grouping? Tell us on the Novartis page.

Studies

Recruiting first, then most recently updated. Showing 11 of 11. All Novartis studies →